Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial

ClinicalTrials.gov ID: NCT00133822

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00133822. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether the administration of risperidone is effective in the treatment of selective serotonin reuptake inhibitor (SSRI)-resistant post-traumatic stress disorder (PTSD) in civilians.

Study identification

NCT ID: NCT00133822
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Emory University; Other
Enrollment: 65 participants

Conditions and interventions

Conditions

Post-Traumatic Stress Disorders

Interventions

Sertraline and Risperidone Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 65 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2004 (Type not available)
Primary completion: Sep 2006 (Actual)
Completion: Sep 2006 (Actual)
Last update posted: Aug 19, 2015

2004 – 2006

United States locations

U.S. sites: 3
U.S. states: 3
U.S. cities: 3

Facility	City	State	ZIP	Site status
Emory University School of Medicine	Atlanta	Georgia	30322	—
Duke University Medical Center South	Durham	North Carolina	27710	—
Medical University of South Carolina	Charleston	South Carolina	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00133822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 19, 2015 · Synced Nov 12, 2026